Ebola vaccine to start clinical trials in early 2015

675

Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson JNJ.N, in another sign that the world's worst outbreak of the virus is mobilizing research into the deadly disease.

J&J said on Thursday that clinical trials of its new vaccine, which includes technology from Danish biotech firm Bavarian Nordic BAVA.CO, would commence in early 2015.

The move follows a decision to begin initial human testing of a GlaxoSmithKline GSK.L vaccine this month and plans to test one developed by Canadian government scientists, which has been licensed to NewLink Genetics NLNK.O, in the autumn.

alarabiya

comments powered by Disqus
Home